Diagnostic Testing Fund – Pediatric Oncology: Solid Tumors

This program supports children with suspected solid tumors by providing access to genetic and precision biomarker testing. Conditions like Wilms tumor and pediatric renal cancers require urgent and specialized diagnostics to accurately classify the disease. Early identification is essential for guiding targeted therapies and surgical planning — especially in young patients, where timing can significantly impact outcomes.